West Oak Capital, LLC Allogene Therapeutics, Inc. Call Options Transaction History
West Oak Capital, LLC
- $2.59 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ALLO
# of Institutions
173Shares Held
153MCall Options Held
185KPut Options Held
66.6K-
Tpg Gp A, LLC Fort Worth, TX18.7MShares$30.3 Million0.84% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$26.6 Million0.0% of portfolio
-
Capital World Investors Los Angeles, CA12.3MShares$19.9 Million0.0% of portfolio
-
Lynx1 Capital Management LP San Juan, PR11.1MShares$17.9 Million5.97% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.07MShares$13.1 Million0.0% of portfolio
About Allogene Therapeutics, Inc.
- Ticker ALLO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 143,807,008
- Market Cap $233M
- Description
- Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...